therapeutics announces - Robuta Search

https://montaratx.com/montara-therapeutics-announces-development-candidate-for-first-brainonly/ Montara Therapeutics Announces Development Candidate for First BrainOnly™-Enabled Program in... Dec 8, 2025 - Montara’s BrainOnly platform is designed to prevent peripheral side effects and concentrate neurological drugs’ activity in the brain via two-drug combination... montara therapeutics announces development candidate first enabled https://www.biospace.com/press-releases/akari-therapeutics-announces-strategic-partnership-with-wuxi-xdc-to-advance-development-of-its-novel-adc-payload-targeting-rna-splicing Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its... therapeutics announces strategic partnership advance development akari wuxi https://pr.dailyastorian.com/article/Aligos-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4?storyId=69eb5c1b25e04a842cd69657 Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Intrado therapeutics announces nasdaq listing inducement grants rule https://globalmediawatch.com/article/908543385-rgenta-therapeutics-announces-two-oral-presentations-highlighting-proprietary-rswitch-technology-at-the-american-society-of-gene-and-cell-therapy Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at... therapeutics announces oral presentations two highlighting proprietary https://www.primmunerx.com/press-releases/primmune-therapeutics-announces-additional-close-of-series-b-financing/ Primmune Therapeutics Announces Additional Close of Series B Financing - Primmune Jan 26, 2026 - SAN DIEGO, January 26, 2026 – Today, Primmune Therapeutics, a biotech company harnessing the power of the innate immune system, announced an additional close... series b financing therapeutics announces additional close https://www.terraytx.com/press/terray-therapeutics-announces-multi-target-collaboration-with-bristol-myers-squibb Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb - Terray... Companies to leverage Terray’s tNova drug discovery platform to identify small molecule therapeutics against targets of interest. The collaboration includes an... bristol myers squibb terray therapeutics announces multi target collaboration https://www.prnewswire.com/news-releases/partner-therapeutics-announces-submission-of-supplemental-biologics-license-application-sbla-to-fda-for-bizengri-zenocutuzumab-zbco-in-nrg1-fusion-positive-cholangiocarcinoma-and-inclusion-in-updated-nccn-clinical-practice-gu-302742366.html Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to... Apr 14, 2026 - /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announces the submission of a supplemental Biologics... therapeutics announces license application partner submission supplemental https://www.biospace.com/press-releases/flare-therapeutics-announces-three-upcoming-poster-presentations-at-aacr-annual-meeting-2026 Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026 -... aacr annual meeting therapeutics announces three upcoming poster presentations flare https://www.flagshippioneering.com/news/press-release/tessera-therapeutics-announces-over-300m-series-c-financing-to-advance-its-gene-writing-platform Tessera Therapeutics Announces Over $300M… | Flagship Pioneering Nov 30, 2023 - Flagship Pioneering is a a biotechnology company that invents platforms and builds companies that change the world. tessera therapeutics flagship pioneering announces https://one-carbon.com/one-carbon-therapeutics-announces-strategic-collaboration-with-tempus-to-advancemolecular-insights-and-enable-precision-oncology-development-of-th9619/ One-carbon Therapeutics Announces Strategic Collaboration with Tempus to Advance Molecular Insights... Mar 17, 2026 - Solna, Sweden, March 17h, 2026. One-carbon Therapeutics, a clinical-stage oncology company pioneering first-in-class targeted therapies based on deep... one carbon therapeutics announces strategic collaboration molecular insights tempus https://ir.lenz-tx.com/news-events/press-releases/detail/39/lenz-therapeutics-announces-us-fda-approval-of-vizz-for-the-treatment-of-presbyopia LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia :: LENZ... VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting…... lenz therapeutics announces us fda approval treatment presbyopia https://www.biospace.com/press-releases/tenvie-therapeutics-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-tnv262-a-fully-cns-penetrant-nlrp3-inhibitor Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV262, a Fully... phase 1 clinical therapeutics announces first subject dosing trial https://www.massgeneral.org/neurology/als/news/healey-center-announces-design-with-keros-therapeutics Sean M. Healey & AMG Center for ALS Announces Design with Keros Therapeutics for Upcoming Healey... healey amg center sean als announces design https://www.prnewswire.com/news-releases/deerfield-management-announces-sale-of-melinta-therapeutics-302546793.html Deerfield Management Announces Sale of Melinta Therapeutics Sep 5, 2025 - /PRNewswire/ -- Deerfield Management Company, an investment firm dedicated to advancing healthcare, announced that it has closed on the sale of its portfolio... deerfield management announces sale therapeutics https://www.manilatimes.net/2026/04/07/tmt-newswire/globenewswire/renovare-therapeutics-inc-announces-company-launch-and-collaboration-with-cu-boulder-awardee-of-up-to-335-million-in-arpa-h-funding-to-advance-osteoarthritis-regenerative-therapies/2315038 Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of... Apr 7, 2026 - BOULDER, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for... therapeutics inc company launch cu boulder renovare announces https://news.rpi.edu/2026/04/01/rpi-announces-doe-under-secretary-science-and-former-ceo-melinta-therapeutics RPI Announces DOE Under Secretary for Science and Former CEO of Melinta Therapeutics as... Rensselaer Polytechnic Institute (RPI) today announced that Darío Gil, Ph.D., Under Secretary for Science at the U.S. former ceo rpi announces doe secretary https://www.prnewswire.com/news-releases/z-squared-announces-completion-of-business-combination-with-coeptis-therapeutics-and-listing-on-the-nasdaq-global-market-302753341.html Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the... Apr 24, 2026 - /PRNewswire/ -- Z Squared, Inc. (Nasdaq: ZSQR) ( announces completion business combination z squared therapeutics